This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Inotrem, Inserm (Institut National De La Santé Et De La Recherche Médicale), Universite Paris Cité. Active years: 2026.
Company Filing History:
1 out of 3 
1 out of 16 
1 out of 72 
Years Active: 2026
Title: The Innovative Contributions of Olivia Lenoir
Introduction
Olivia Lenoir is a prominent inventor based in Paris, France. She has made significant strides in the field of medical research, particularly focusing on treatments for sickle cell disease. Her work has the potential to improve the quality of life for many patients suffering from this condition.
Latest Patents
Olivia Lenoir holds a patent titled "TREM-1 Inhibitors for the Treatment of Vaso-Occlusions and Tissue Injuries in Patients Suffering from Sickle Cell Disease." This innovative approach aims to address critical health challenges faced by individuals with sickle cell disease.
Career Highlights
Throughout her career, Olivia has worked with esteemed institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université Paris Cité. Her contributions to these organizations have been instrumental in advancing research and development in her field.
Collaborations
Olivia has collaborated with notable colleagues, including Pierre-Louis Tharaux and Thomas Mintz. These partnerships have enriched her research and expanded the impact of her work.
Conclusion
Olivia Lenoir's innovative contributions to medical research exemplify the vital role of inventors in addressing complex health issues. Her dedication to improving treatments for sickle cell disease highlights the importance of continued research and collaboration in the field.